KaloBios Pharma (KBIO) Trading Halt Remains in Effect Despite CEO Firing Update
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/24/2026
- S&P 500, Nasdaq futures tick up as tech steadies, Micron earnings eyed
- Brent extends losses on expectations of smoother crude flows via Hormuz
- Alphabet added to Dow Jones Industrial Average, Verizon dropped
- Chip stocks plunge, but bargain-hunters limit scale of tech rout
- FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
- Needham Starts NeoVolta (NEOV) at Buy
- Wall Street ends lower on semiconductor selloff as AI spending concerns mount
- NextEra to discuss paying about $76 per share for Dominion, Bloomberg News reports
- Campbell Soup (CPB) Declares $0.39 Quarterly Dividend; 7.7% Yield
- KKR launches Helix with over $10 billion to build AI infrastructure
Martin Shkreli Says His Twitter Account was Hacked
December 21, 2015 11:17 AM ESTMartin Shkreli said he has regained control of his Twitter account after being hacked.
The former Turing Pharmaceuticals and KaloBios Pharma (NASDAQ: KBIO) CEO was arrested last week for securities fraud related to past dealings with his hedge fund and former company... More
KaloBios Pharma (KBIO) Terminates CEO Martin Shkreli
December 21, 2015 9:33 AM ESTKaloBios Pharmaceuticals, Inc. (Nasdaq: KBIO) announced that on December 17, 2015, Martin Shkreli was terminated as Chief Executive Officer of the Company and resigned from his position as a member of the board of directors. In addition, on December 17, 2015, Tony Chase resigned from... More
Martin Shkreli attributes arrest to drug-price hikes: WSJ
December 21, 2015 1:51 AM EST(Reuters) - Martin Shkreli, the pharmaceutical entrepreneur facing U.S. charges of securities fraud, has said he had been the target of legal authorities for his much-criticized drug-price hikes and his over-the-top public persona, the Wall Street Journal reported.
Shkreli, who was arrested on Thursday and released soon after on a $5 million bond, has been charged for engaging in what U.S. prosecutors said was a Ponzi-like scheme at his former hedge fund MSMB Capital Management and Retrophin Inc, a company he headed... More
